U.S Class(es): 100, 101
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Dec-03-2023 | TOTAL INVALIDATION PROCESSED BY THE IB | INNTP | |
Nov-16-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | INTSP | |
Nov-15-2023 | INVALIDATION PROCESSED | INPCP | |
Nov-10-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | INTRP | |
Mar-10-2023 | CANCELLED SECTION 71 | C71TO | |
Oct-21-2016 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Sep-30-2016 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Sep-30-2016 | FINAL DISPOSITION PROCESSED | FIMPP | |
Sep-29-2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Sep-23-2016 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | OPNXP | |
Aug-30-2016 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Jun-14-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
Jun-01-2016 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Jun-01-2016 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
May-25-2016 | NOTICE OF PUBLICATION | NPUBO | |
May-04-2016 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
May-04-2016 | ASSIGNED TO EXAMINER | DOCKD | |
Mar-29-2016 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Mar-25-2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Mar-24-2016 | SN ASSIGNED FOR SECT 66A APPL FROM IB | REPRM |